Apple to Temporarily Disable Blood Oxygen Tracking on New Watch Ultra 2 and Series 9 in the US Amid Legal Disputes.

Apple has officially announced that it will temporarily disable blood oxygen tracking on the Watch Ultra 2 and Series 9 smartwatches in the United States due to an ongoing legal battle with medical technology company Masimo. New sales of these smartwatches in the US will not include the SpO2 feature until the legal disputes are resolved. However, existing units in the market and those already shipped to retailers will continue to function normally, and users outside the US will not be affected. This move allows Apple to continue selling the smartwatches in the US market, despite the ongoing legal issues.